Authors:
Pierce, RA
Field, ED
Mutis, T
Golovina, TN
Von Kap-Herr, C
Wilke, M
Pool, J
Shabanowitz, J
Pettenati, MJ
Eisenlohr, LC
Hunt, DF
Goulmy, E
Engelhard, VH
Citation: Ra. Pierce et al., The HA-2 minor histocompatibility antigen is derived from a diallelic geneencoding a novel human class I myosin protein, J IMMUNOL, 167(6), 2001, pp. 3223-3230
Authors:
Mutis, T
Gillespie, G
Schrama, E
Falkenburg, JHF
Moss, P
Goulmy, E
Citation: T. Mutis et al., Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease, NAT MED, 5(7), 1999, pp. 839-842
Citation: T. Mutis et E. Goulmy, Induction of minor histocompatibility antigen HA-1-specific cytotoxic T cells for the treatment of leukemia after allogeneic stem cell transplantation - Response, BLOOD, 94(12), 1999, pp. 4376-4376
Authors:
Mutis, T
Verdijk, R
Schrama, E
Esendam, B
Brand, A
Goulmy, E
Citation: T. Mutis et al., Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens, BLOOD, 93(7), 1999, pp. 2336-2341